Blood cancers, Myelofibrosis
Results
Phase 3
This trial compared pacritinib with other available treatments for myelofibrosis.
Myelofibrosis (pronounced my-eh-lo-fy-bro-sis) is a rare blood disorder. A small number of people with myelofibrosis go on to develop acute myeloid leukaemia.
Recruitment start: 15 June 2013
Recruitment end: 30 June 2014
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Adam Mead
Cell Therapeutics Inc (CTI)
NIHR Clinical Research Network: Cancer
Last reviewed: 21 Aug 2018
CRUK internal database number: 10767
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
